Cargando…
The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
INTRODUCTION: In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five years. The aim of this study was to (1) assess the r...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460719/ https://www.ncbi.nlm.nih.gov/pubmed/37479944 http://dx.doi.org/10.1007/s10549-023-07029-4 |
_version_ | 1785097693527277568 |
---|---|
author | Waaijer, M. E.C. Lemij, A. A. de Boer, A. Z. Bastiaannet, E. van den Bos, F. Derks, M. G.M. Kroep, J. R. Liefers, G. J. Portielje, J. E.A. de Glas, N. A. |
author_facet | Waaijer, M. E.C. Lemij, A. A. de Boer, A. Z. Bastiaannet, E. van den Bos, F. Derks, M. G.M. Kroep, J. R. Liefers, G. J. Portielje, J. E.A. de Glas, N. A. |
author_sort | Waaijer, M. E.C. |
collection | PubMed |
description | INTRODUCTION: In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five years. The aim of this study was to (1) assess the risk of distant metastases and other cause mortality over ten years in women aged 65 and older with stage I-III breast cancer treated with PET, (2) whether this was associated with geriatric characteristics and comorbidities and to (3) describe the reasons on which the choice for PET was made. METHODS: Women were included from the retrospective FOCUS cohort, which comprises all incident women diagnosed with breast cancer aged 65 or older between January 1997 and December 2004 in the Comprehensive Cancer Center Region West in the Netherlands. We selected women (N = 257) with stage I-III breast cancer and treated with PET from this cohort. Patient characteristics (including comorbidity, polypharmacy, walking, cognitive and sensory impairment), treatment and tumor characteristics were retrospectively extracted from charts. Outcomes were distant metastasis and other cause mortality. Cumulative incidences were calculated using the Cumulative Incidence for Competing Risks method (CICR); and subdistribution hazard ratios (SHR) were tested between groups based on age, geriatric characteristics and comorbidity with the Fine and Gray model. RESULTS: Women treated with PET were on average 84 years old and 41% had one or more geriatric characteristics. Other cause mortality exceeded the cumulative incidence of distant metastasis over ten years (83 versus 5.6%). The risk of dying from another cause further increased in women with geriatric characteristics (SHR 2.06, p < 0.001) or two or more comorbidities (SHR 1.72, p < 0.001). Often the reason for omitting surgery was not recorded (52.9%), but if recorded surgery was omitted mainly at the patient’s request (18.7%). DISCUSSION: This study shows that the cumulative incidence of distant metastasis is much lower than other cause mortality in older women with breast cancer treated with PET, especially in the presence of geriatric characteristics or comorbidities. This confirms the importance of assessment of geriatric characteristics to aid counseling of older women. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-023-07029-4. |
format | Online Article Text |
id | pubmed-10460719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-104607192023-08-29 The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy Waaijer, M. E.C. Lemij, A. A. de Boer, A. Z. Bastiaannet, E. van den Bos, F. Derks, M. G.M. Kroep, J. R. Liefers, G. J. Portielje, J. E.A. de Glas, N. A. Breast Cancer Res Treat Epidemiology INTRODUCTION: In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five years. The aim of this study was to (1) assess the risk of distant metastases and other cause mortality over ten years in women aged 65 and older with stage I-III breast cancer treated with PET, (2) whether this was associated with geriatric characteristics and comorbidities and to (3) describe the reasons on which the choice for PET was made. METHODS: Women were included from the retrospective FOCUS cohort, which comprises all incident women diagnosed with breast cancer aged 65 or older between January 1997 and December 2004 in the Comprehensive Cancer Center Region West in the Netherlands. We selected women (N = 257) with stage I-III breast cancer and treated with PET from this cohort. Patient characteristics (including comorbidity, polypharmacy, walking, cognitive and sensory impairment), treatment and tumor characteristics were retrospectively extracted from charts. Outcomes were distant metastasis and other cause mortality. Cumulative incidences were calculated using the Cumulative Incidence for Competing Risks method (CICR); and subdistribution hazard ratios (SHR) were tested between groups based on age, geriatric characteristics and comorbidity with the Fine and Gray model. RESULTS: Women treated with PET were on average 84 years old and 41% had one or more geriatric characteristics. Other cause mortality exceeded the cumulative incidence of distant metastasis over ten years (83 versus 5.6%). The risk of dying from another cause further increased in women with geriatric characteristics (SHR 2.06, p < 0.001) or two or more comorbidities (SHR 1.72, p < 0.001). Often the reason for omitting surgery was not recorded (52.9%), but if recorded surgery was omitted mainly at the patient’s request (18.7%). DISCUSSION: This study shows that the cumulative incidence of distant metastasis is much lower than other cause mortality in older women with breast cancer treated with PET, especially in the presence of geriatric characteristics or comorbidities. This confirms the importance of assessment of geriatric characteristics to aid counseling of older women. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-023-07029-4. Springer US 2023-07-21 2023 /pmc/articles/PMC10460719/ /pubmed/37479944 http://dx.doi.org/10.1007/s10549-023-07029-4 Text en © The Author(s) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Epidemiology Waaijer, M. E.C. Lemij, A. A. de Boer, A. Z. Bastiaannet, E. van den Bos, F. Derks, M. G.M. Kroep, J. R. Liefers, G. J. Portielje, J. E.A. de Glas, N. A. The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy |
title | The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy |
title_full | The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy |
title_fullStr | The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy |
title_full_unstemmed | The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy |
title_short | The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy |
title_sort | impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460719/ https://www.ncbi.nlm.nih.gov/pubmed/37479944 http://dx.doi.org/10.1007/s10549-023-07029-4 |
work_keys_str_mv | AT waaijermec theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT lemijaa theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT deboeraz theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT bastiaannete theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT vandenbosf theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT derksmgm theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT kroepjr theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT liefersgj theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT portieljejea theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT deglasna theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT waaijermec impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT lemijaa impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT deboeraz impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT bastiaannete impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT vandenbosf impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT derksmgm impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT kroepjr impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT liefersgj impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT portieljejea impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy AT deglasna impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy |